T2 Biosystems Inc. [NASDAQ: TTOO] traded at a low on 06/23/21, posting a 0.00 loss after which it closed the day’ session at $1.23. The company report on June 21, 2021 that T2 Biosystems to Participate at Clinical Conferences in June and July 2021.
Company will underscore the importance of rapid diagnostic technology for detecting bloodstream infections (BSIs) and sepsis.
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced the Company’s participation in three virtual conferences this summer.
The results of the trading session contributed to over 2058001 shares changing hands. Over the past one week, the price volatility of T2 Biosystems Inc. stands at 5.03% while the volatility over the past one month is 8.20%.
The market cap for TTOO stock reached $186.03 million, with 148.23 million shares outstanding and 143.13 million shares in the current float. Compared to the average trading volume of 4.45M shares, TTOO reached a trading volume of 2058001 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about T2 Biosystems Inc. [TTOO]?
Alliance Global Partners have made an estimate for T2 Biosystems Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 27, 2021. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on October 08, 2020, representing the official price target for T2 Biosystems Inc. stock.
The Average True Range (ATR) for T2 Biosystems Inc. is set at 0.09, with the Price to Sales ratio for TTOO stock in the period of the last 12 months amounting to 8.27.
How has TTOO stock performed recently?
T2 Biosystems Inc. [TTOO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.52. With this latest performance, TTOO shares gained by 11.82% in over the last four-week period, additionally plugging by 6.03% over the last 6 months – not to mention a rise of 1.65% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TTOO stock in for the last two-week period is set at 45.45, with the RSI for the last a single of trading hit 42.25, and the three-weeks RSI is set at 45.86 for T2 Biosystems Inc. [TTOO]. The present Moving Average for the last 50 days of trading for this stock 1.2600, while it was recorded at 1.2540 for the last single week of trading, and 1.5211 for the last 200 days.
T2 Biosystems Inc. [TTOO]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and T2 Biosystems Inc. [TTOO] shares currently have an operating margin of -221.72 and a Gross Margin at -13.87. T2 Biosystems Inc.’s Net Margin is presently recorded at -258.12.
Return on Total Capital for TTOO is now -102.55, given the latest momentum, and Return on Invested Capital for the company is -289.22. When it comes to the capital structure of this company, T2 Biosystems Inc. [TTOO] has a Total Debt to Total Equity ratio set at 652.29. Additionally, TTOO Total Debt to Total Capital is recorded at 86.71, with Total Debt to Total Assets ending up at 71.98. Long-Term Debt to Equity for the company is recorded at 639.10, with the Long-Term Debt to Total Capital now at 84.95.
Reflecting on the efficiency of the workforce at the company, T2 Biosystems Inc. [TTOO] managed to generate an average of -$316,203 per employee. Receivables Turnover for the company is 4.58 with a Total Asset Turnover recorded at a value of 0.34.T2 Biosystems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.90 and a Current Ratio set at 4.30.
Earnings analysis for T2 Biosystems Inc. [TTOO]
With the latest financial reports released by the company, T2 Biosystems Inc. posted -0.09/share EPS, while the average EPS was predicted by analysts to be reported at -0.15/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 40.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TTOO.
Insider trade positions for T2 Biosystems Inc. [TTOO]
There are presently around $32 million, or 17.60% of TTOO stock, in the hands of institutional investors. The top three institutional holders of TTOO stocks are: VANGUARD GROUP INC with ownership of 6,517,731, which is approximately 5.37% of the company’s market cap and around 0.30% of the total institutional ownership; GOLDMAN SACHS GROUP INC, holding 4,358,817 shares of the stock with an approximate value of $5.36 million in TTOO stocks shares; and BLACKROCK INC., currently with $3.7 million in TTOO stock with ownership of nearly 36.336% of the company’s market capitalization.
Positions in T2 Biosystems Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 51 institutional holders increased their position in T2 Biosystems Inc. [NASDAQ:TTOO] by around 6,988,179 shares. Additionally, 29 investors decreased positions by around 2,084,691 shares, while 14 investors held positions by with 17,267,127 shares. The mentioned changes placed institutional holdings at 26,339,997 shares, according to the latest SEC report filing. TTOO stock had 27 new institutional investments in for a total of 1,975,186 shares, while 10 institutional investors sold positions of 459,173 shares during the same period.